Publications by authors named "Jon Ottaway"

Claim this Profile
D
DyNeuMo Mk-1: Design and pilot validation of an investigational motion-adaptive neurostimulator with integrated chronotherapy.
Mayela Zamora, Robert Toth, Francesca Morgante, Jon Ottaway, Tom Gillbe

Exp Neurol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DyNeuMo Mk-2: An Investigational Circadian-Locked Neuromodulator with Responsive Stimulation for Applied Chronobiology.
Robert Toth, Mayela Zamora, Jon Ottaway, Tom Gillbe, Sean Martin

Conf Proc IEEE Int Conf Syst Man Cybern· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.
Wendy R Parulekar, Andrew G Day, Jon A Ottaway, Lois E Shepherd, Maureen E Trudeau

J Clin Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Graeme G Duncan, Joel B Epstein, Dongsheng Tu, Samy El Sayed, Andrea Bezjak, Jon Ottaway

Head Neck· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.
Jean-Yves Douillard, Christian Peschel, Frances Shepherd, Luis Paz-Ares, Andrew Arnold, Jon Ottaway

Lung Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis